This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Today's Health Winners and Losers

NitroMed (NTMD) shares slid 17% after the drugmaker posted fourth-quarter results that fell short of expectations. The company reported a loss of $31.6 million, or $1.04 a share, on sales of $3.7 million. Analysts expected a smaller loss of 94 cents a share, with sales of $4.35 million. A year earlier, the company had a loss of $9.7 million, or 36 cents a share, on sales of $9.5 million. Shares were down $1.94 to $9.45.

Shares of Hanger Orthopedic (HGR - Get Report) rose 8% after the company posted fourth-quarter earnings that topped forecasts by a penny. The company reported a profit of $6.7 million, or 30 cents a share, on sales of $149.2 million. Excluding one-time items, the company earned 14 cents a share. Analysts expected earnings of 13 cents a share. During the year-earlier quarter, the company earned $2.6 million, or 12 cents a share, on sales of $145.9 million. Shares recently had gained 49 cents to $6.75.

Other health care volume movers included Pfizer (PFE - Get Report), down 19 cents to $26.07; Elan (ELN), up 1 cent to $13; Boston Scientific (BSX), down 26 cents to $23.74; Schering-Plough (SGP), down 18 cents to $18.18; Genta (GNTA), down 10 cents to $2.72; Generex Biotech (GNBT), down 12 cents to $2.19; Johnson & Johnson (JNJ), up 25 cents to $57.91; Novavax (NVAX), down 31 cents to $5.38; Amgen (AMGN), down 23 cents to $75.82; Merck (MRK - Get Report), up 13 cents to $35.09; and Bristol-Myers Squibb (BMY), down 8 cents to $22.69.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABPI $0.00 0.00%
GNBT $0.01 -12.38%
BDSI $6.59 5.80%
HGR $13.96 2.10%
MRK $50.96 2.30%


Chart of I:DJI
DOW 16,912.29 +122.10 0.73%
S&P 500 1,993.05 +13.13 0.66%
NASDAQ 4,783.2490 +34.8880 0.73%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs